2 High-Yield Dividend Stocks Worth Buying Before 2026 Ends
Verizon (VZ) and Pfizer (PFE) are highlighted for their high dividend yields and growth prospects. Verizon reported subscriber growth and raised guidance, offering a 6.5% yield. Pfizer declared a 6.1% yield and is advancing its oncology pipeline. Both stocks are positioned for income investors before year-end.
How this was made
The 30-second read
Why it matters
It may influence marginal retail/income flows, but it does not provide a clear new, time-critical corporate event beyond dividend declarations and general growth/pipeline descriptions.
Market read
Useful for dividend-focused positioning, but the trading signal is weak because the piece is promotional and lacks a clearly first-reported, market-moving catalyst.
What to watch
The article does not address valuation, payout coverage, debt/refinancing risk, or competitive pipeline risks that typically drive dividend durability.
Background
The article is a year-end income-investor pitch highlighting Verizon and Pfizer for dividend yield and business fundamentals.
Ticker impact
Verizon is cited for raised full-year guidance, subscriber growth, and a declared September 2026 quarterly dividend of about $0.71.
Likely modest support as investors price in steadier cash flows and the reiterated dividend commitment.
The article provides specific dividend and guidance-related details, but it is still framed as a year-end buying list rather than a first-report market-moving disclosure.
Pfizer is cited for declaring a fourth-quarter dividend of $0.43 and reporting a pipeline of 96 programs, including 31 in phase 3.
Likely mild upward bias from dividend support and perceived pipeline optionality.
The piece includes concrete dividend and pipeline figures, but it is promotional and does not clearly establish that these are newly disclosed facts versus previously reported updates.
Market effects
Reinforces a defensive, dividend-income rotation narrative toward telecom and large-cap pharma.
Primarily US-focused, with potential mild sentiment spillover to other dividend payers.
Limited, as the story is company-specific and US-listed.
Counterpoint
High-yield stocks can underperform if dividend sustainability or growth assumptions deteriorate; a listicle framing may overstate near-term certainty.
Key entities
- companyVerizon Communications
US telecom operator discussed for subscriber growth, raised full-year guidance, and a declared quarterly dividend.
- companyPfizer
US pharma company discussed for a declared quarterly dividend and an oncology and clinical pipeline overview.
